Stock Screener
Stock Research
Market Indexes
Precious Metals
Energy
Commodities
Exchange Rates
Interest Rates
Futures
Economy
Global Metrics

Biogen Price to Book Ratio 2006-2020 | BIIB

Historical price to book ratio values for Biogen (BIIB) over the last 10 years. The current price to book ratio for Biogen as of September 24, 2020 is 3.82.

Please refer to the Stock Price Adjustment Guide for more information on our historical prices.
  
Biogen Price/Book Ratio Historical Data
Date Stock Price Book Value per Share Price to Book Ratio
2020-09-24 270.04 3.79
2020-06-30 267.55 $71.32 3.75
2020-03-31 316.38 $74.71 4.23
2019-12-31 296.73 $76.57 3.88
2019-09-30 232.82 $76.92 3.03
2019-06-30 233.87 $70.20 3.33
2019-03-31 236.38 $71.29 3.32
2018-12-31 300.92 $66.08 4.55
2018-09-30 353.31 $68.29 5.17
2018-06-30 290.24 $60.83 4.77
2018-03-31 273.82 $66.53 4.12
2017-12-31 318.57 $59.57 5.35
2017-09-30 313.12 $60.76 5.15
2017-06-30 271.36 $54.74 4.96
2017-03-31 273.42 $54.06 5.06
2016-12-31 261.39 $56.18 4.65
2016-09-30 288.53 $55.68 5.18
2016-06-30 222.89 $52.04 4.28
2016-03-31 239.95 $47.15 5.09
2015-12-31 282.37 $42.89 6.58
2015-09-30 268.35 $47.41 5.66
2015-06-30 372.33 $53.46 6.96
2015-03-31 389.19 $49.61 7.85
2014-12-31 312.88 $46.10 6.79
2014-09-30 304.92 $44.17 6.90
2014-06-30 290.63 $40.51 7.18
2014-03-31 281.93 $38.54 7.32
2013-12-31 257.69 $36.48 7.06
2013-09-30 221.92 $34.40 6.45
2013-06-30 198.36 $33.25 5.97
2013-03-31 177.54 $30.92 5.74
2012-12-31 134.91 $29.44 4.58
2012-09-30 137.53 $28.16 4.88
2012-06-30 133.08 $26.53 5.02
2012-03-31 116.14 $26.33 4.41
2011-12-31 101.44 $26.55 3.82
2011-09-30 85.86 $25.66 3.35
2011-06-30 98.55 $24.97 3.95
2011-03-31 67.72 $23.48 2.88
2010-12-31 61.80 $22.66 2.73
2010-09-30 51.73 $21.28 2.43
2010-06-30 43.74 $21.54 2.03
2010-03-31 52.90 $22.29 2.37
2009-12-31 49.31 $21.71 2.27
2009-09-30 46.57 $22.81 2.04
2009-06-30 41.62 $21.62 1.92
2009-03-31 48.32 $20.86 2.32
2008-12-31 43.90 $20.25 2.17
2008-09-30 46.35 $19.77 2.34
2008-06-30 51.52 $19.03 2.71
2008-03-31 56.86 $18.88 3.01
2007-12-31 52.47 $18.72 2.80
2007-09-30 61.14 $17.02 3.59
2007-06-30 49.31 $16.10 3.06
2007-03-31 40.91 $21.47 1.91
2006-12-31 45.34 $21.14 2.14
2006-09-30 41.18 $20.45 2.01
2006-06-30 42.69 $20.40 2.09
2006-03-31 43.41 $20.77 2.09
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $43.093B $14.378B
Biogen is a leading biopharmaceutical company engaged in the research, development and marketing of targeted therapies for the treatment of cancer, autoimmune and inflammatory diseases. The company owns industry leading brands for the treatment of multiple sclerosis, next-generation treatments for hemophilia, and a deep clinical pipeline ranging from Alzheimer's disease, lupus nephritis to neuropathic pain.
Stock Name Country Market Cap PE Ratio
Amgen (AMGN) United States $142.083B 15.43
Bristol Myers Squibb (BMY) United States $133.476B 10.28
CSL (CSLLY) Australia $94.786B 0.00
Gilead Sciences (GILD) United States $79.097B 11.39
Vertex Pharmaceuticals (VRTX) United States $68.716B 38.35
Regeneron Pharmaceuticals (REGN) United States $60.132B 22.99
Illumina (ILMN) United States $39.858B 46.35
Seattle Genetics (SGEN) United States $31.192B 0.00
Moderna (MRNA) United States $26.500B 0.00
BeiGene (BGNE) Cayman Islands $24.831B 0.00
Alexion Pharmaceuticals (ALXN) United States $24.642B 10.27
Genmab (GMAB) Denmark $23.580B 14.90
Genmab (GNMSF) Denmark $21.776B 5.02
SINO PHARMACEUT (SBMFF) Hong Kong, SAR China $21.715B 0.00
Immunomedics (IMMU) United States $19.687B 0.00
Incyte (INCY) United States $18.802B 0.00
Horizon Therapeutics Public (HZNP) Ireland $16.471B 38.54
Alnylam Pharmaceuticals (ALNY) United States $15.598B 0.00
Bio-Rad Laboratories (BIO.B) United States $15.077B 68.19
BioNTech SE (BNTX) Germany $14.442B 0.00
BioMarin Pharmaceutical (BMRN) United States $14.223B 103.20
ARGENX SE-ADR (ARGX) Netherlands $11.557B 0.00
QIAGEN (QGEN) Netherlands $11.554B 29.32
Sarepta Therapeutics (SRPT) United States $11.302B 0.00
Exact Sciences (EXAS) United States $11.165B 0.00
Guardant Health (GH) United States $10.524B 0.00
Bio-Techne Corp (TECH) United States $9.369B 64.28
Galapagos (GLPG) Belgium $8.942B 32.40
Ascendis Pharma (ASND) Denmark $7.715B 0.00
SWEDISH ORP BIO (BIOVF) Sweden $7.643B 19.01
Repligen (RGEN) United States $7.475B 118.65
Exelixis (EXEL) United States $7.329B 26.65
Mirati Therapeutics (MRTX) United States $7.104B 0.00
MyoKardia (MYOK) United States $6.858B 0.00
Acceleron Pharma (XLRN) United States $6.653B 0.00
Adaptive Biotechnologies (ADPT) United States $6.547B 0.00
ACADIA Pharmaceuticals (ACAD) United States $6.378B 0.00
Momenta Pharmaceuticals (MNTA) United States $6.224B 0.00
Novavax (NVAX) United States $6.224B 0.00
CRISPR Therapeutics AG (CRSP) Switzerland $5.943B 184.11
Emergent Biosolutions (EBS) United States $5.411B 21.43
Ultragenyx Pharmaceutical (RARE) United States $5.013B 0.00
Blueprint Medicines (BPMC) United States $4.955B 0.00
Zai Lab (ZLAB) China $4.452B 0.00
China Biologic Products (CBPO) China $4.375B 25.97
Vir Biotechnology (VIR) United States $4.247B 0.00
Arena Pharmaceuticals (ARNA) United States $4.194B 0.00
MorphoSys AG (MOR) Germany $4.164B 54.57
NeoGenomics (NEO) United States $3.814B 1151.33
Denali Therapeutics (DNLI) United States $3.752B 0.00
Legend Biotech (LEGN) United States $3.735B 0.00
Bluebird Bio (BLUE) United States $3.705B 0.00
Reata Pharmaceuticals (RETA) United States $3.650B 0.00
Halozyme Therapeutics (HALO) United States $3.546B 0.00
Amicus Therapeutics (FOLD) United States $3.447B 0.00
Insmed (INSM) United States $3.322B 0.00
Principia Biopharma (PRNB) United States $3.319B 0.00
Global Blood Therapeutics (GBT) United States $3.296B 0.00
Fate Therapeutics (FATE) United States $3.167B 0.00
Twist Bioscience (TWST) United States $2.890B 0.00
Deciphera Pharmaceuticals (DCPH) United States $2.874B 0.00
Alkermes (ALKS) Ireland $2.677B 56.10
Inovio Pharmaceuticals (INO) United States $2.675B 0.00
I-Mab (IMAB) China $2.391B 0.00
Sorrento Therapeutics (SRNE) United States $2.323B 0.00
PHARMA MAR SA (PHMMF) Spain $2.208B 0.00
Mesoblast (MESO) Australia $2.059B 0.00
Zymeworks (ZYME) Canada $1.983B 0.00
Editas Medicine (EDIT) United States $1.958B 0.00
Seres Therapeutics (MCRB) United States $1.942B 0.00
BAVARIAN NORDIC (BVNRY) Denmark $1.926B 21.57
Akcea Therapeutics (AKCA) United States $1.843B 0.00
Intra-Cellular Therapies (ITCI) United States $1.843B 0.00
Forma Therapeutics Holdings (FMTX) United States $1.779B 0.00
Revance Therapeutics (RVNC) United States $1.746B 0.00
Eidos Therapeutics (EIDX) United States $1.699B 0.00
UniQure (QURE) Netherlands $1.688B 0.00
Ligand Pharmaceuticals (LGND) United States $1.498B 50.64
Cytokineticsorporated (CYTK) United States $1.486B 0.00
Amarin (AMRN) Ireland $1.419B 0.00
Viela Bio (VIE) United States $1.411B 0.00
Zealand Pharma (ZEAL) Denmark $1.406B 0.00
Dicerna Pharmaceuticals (DRNA) United States $1.404B 0.00
Sangamo Therapeutics (SGMO) United States $1.394B 0.00
Beam Therapeutics (BEAM) United States $1.350B 0.00
Zealand Pharma (ZLDPF) Denmark $1.339B 0.00
Coherus BioSciences (CHRS) United States $1.300B 7.58
Mersana Therapeutics (MRSN) United States $1.299B 0.00
Intercept Pharmaceuticals (ICPT) United States $1.289B 0.00
Intellia Therapeutics (NTLA) United States $1.238B 0.00
Epizyme (EPZM) United States $1.212B 0.00
Arcus Biosciences (RCUS) United States $1.146B 0.00
Compugen (CGEN) Israel $1.115B 0.00
Nabriva Therapeutics AG (NBRV) Ireland $1.094B 0.00
NGM Biopharmaceuticals (NGM) United States $1.073B 0.00
REGENXBIO (RGNX) United States $1.066B 0.00
Athenex (ATNX) United States $1.056B 0.00
Adaptimmune Therapeutics (ADAP) United Kingdom $1.034B 0.00
Castle Biosciences (CSTL) United States $0.990B 0.00
Arvinas (ARVN) United States $0.963B 0.00
Alcobra (ARCT) United States $0.950B 0.00
Heska (HSKA) United States $0.921B 0.00
Adverum Biotechnologies (ADVM) United States $0.909B 0.00
Myriad Genetics (MYGN) United States $0.900B 0.00
Retrophin (RTRX) United States $0.900B 0.00
Alector (ALEC) United States $0.889B 0.00
OXFORD BIOMEDCL (OXBDF) United Kingdom $0.830B 0.00
Vericel (VCEL) United States $0.819B 0.00
Cellectis S.A (CLLS) France $0.798B 0.00
Agenus (AGEN) United States $0.787B 0.00
Pliant Therapeutics (PLRX) United States $0.782B 0.00
Morphic Holding (MORF) United States $0.765B 0.00
NantKwest (NK) United States $0.756B 0.00
Protagonist Therapeutics (PTGX) United States $0.752B 0.00
Pharming Group (PHGUF) Netherlands $0.714B 16.29
MiMedx (MDXG) United States $0.710B 0.00
Codexis (CDXS) United States $0.697B 0.00
VBI Vaccines (VBIV) United States $0.696B 0.00
Frequency Therapeutics (FREQ) United States $0.685B 0.00
Kadmon Holdings (KDMN) United States $0.659B 0.00
Intrexon (PGEN) United States $0.646B 0.00
Cara Therapeutics (CARA) United States $0.644B 0.00
Sinovac Biotech (SVA) China $0.640B 43.13
Northwest Biotherapeutics (NWBO) United States $0.626B 0.00
Basilea Pharmaceutica AG (BPMUF) Switzerland $0.596B 0.00
Autolus Therapeutics (AUTL) United Kingdom $0.571B 0.00
Scholar Rock Holding (SRRK) United States $0.532B 0.00
ZIOPHARM Oncology Inc (ZIOP) United States $0.529B 0.00
Syndax Pharmaceuticals (SNDX) United States $0.528B 0.00
Albireo Pharma (ALBO) United States $0.527B 0.00
Clovis Oncology (CLVS) United States $0.527B 0.00
Geron (GERN) United States $0.522B 0.00
Forte Biosciences (FBRX) United States $0.521B 0.00
Vanda Pharmaceuticals (VNDA) United States $0.521B 4.56
Dynavax Technologies (DVAX) United States $0.496B 0.00
Cel-Sci (CVM) United States $0.494B 0.00
Celldex Therapeutics (CLDX) United States $0.479B 0.00
Aquinox Pharmaceuticals (NLTX) United States $0.476B 0.00
Orchard Therapeutics (ORTX) United Kingdom $0.473B 0.00
Anika Therapeutics (ANIK) United States $0.463B 20.22
MeiraGTx Holdings (MGTX) United States $0.459B 0.00
IVERIC Bio (ISEE) United States $0.452B 0.00
Kala Pharmaceuticals (KALA) United States $0.447B 0.00
Cue Biopharma (CUE) United States $0.447B 0.00
Pfenex (PFNX) United States $0.436B 0.00
MannKind (MNKD) United States $0.429B 0.00
Starpharma Holdings (SPHRY) Australia $0.428B 0.00
Avid Bioservices (CDMO) United States $0.414B 0.00
UROGEN PHARMA (URGN) United States $0.410B 0.00
Syros Pharmaceuticals (SYRS) United States $0.408B 0.00
AnaptysBio (ANAB) United States $0.404B 0.00
Prothena (PRTA) Ireland $0.404B 0.00
Trevena (TRVN) United States $0.387B 0.00
Amryt Pharma (AMYT) United Kingdom $0.386B 0.00
Xenon Pharmaceuticals (XENE) Canada $0.386B 0.00
Puma Biotechnology (PBYI) United States $0.384B 0.00
Athersys (ATHX) United States $0.377B 0.00
BioDelivery Sciences (BDSI) United States $0.374B 26.50
Sutro Biopharma (STRO) United States $0.371B 0.00
Kamada (KMDA) Israel $0.368B 17.60
WAVE Life Sciences (WVE) Singapore $0.365B 0.00
Bicycle Therapeutics (BCYC) United Kingdom $0.359B 0.00
Cellular Biomedicine (CBMG) United States $0.354B 0.00
IBio (IBIO) United States $0.354B 0.00
Fortress Biotech (FBIO) United States $0.349B 0.00
ANI Pharmaceuticals (ANIP) United States $0.346B 8.18
AC Immune SA (ACIU) Switzerland $0.344B 0.00
PDL BioPharma (PDLI) United States $0.344B 0.00
Merus (MRUS) Netherlands $0.343B 0.00
Aeglea BioTherapeutics (AGLE) United States $0.307B 0.00
AMAG Pharmaceuticals (AMAG) United States $0.306B 0.00
CytomX Therapeutics (CTMX) United States $0.305B 0.00
Innate Pharma S.A (IPHA) France $0.292B 0.00
Precision BioSciences (DTIL) United States $0.274B 0.00
Cardiff Oncology (CRDF) United States $0.264B 0.00
Paratek Pharmaceuticals (PRTK) United States $0.261B 0.00
Selecta Biosciences (SELB) United States $0.260B 0.00
Affimed (AFMD) Germany $0.252B 0.00
ChromaDex (CDXC) United States $0.252B 0.00
OSMOTICA PHARM (OSMT) United States $0.250B 0.00
Prometic Life Sciences (LMNL) Canada $0.249B 0.00
Cyclerion Therapeutics (CYCN) United States $0.247B 0.00
Arbutus Biopharma (ABUS) United States $0.244B 0.00
Pluristem Therapeutics (PSTI) Israel $0.232B 0.00
NextCure (NXTC) United States $0.226B 0.00
TELA Bio (TELA) United States $0.225B 0.00
Verastem (VSTM) United States $0.212B 0.00
HOOKIPA Pharma (HOOK) United States $0.209B 0.00
XOMA (XOMA) United States $0.201B 0.00
Spero Therapeutics (SPRO) United States $0.199B 0.00
Dyadic (DYAI) United States $0.198B 0.00
Aduro Biotech (ADRO) United States $0.189B 0.00
POXEL SA FRANCE (PXXLF) France $0.188B 0.00
Liquidia Technologies (LQDA) United States $0.185B 0.00
ADMA Biologics Inc (ADMA) United States $0.183B 0.00
Kindred Biosciences (KIN) United States $0.183B 0.00
Biofrontera AG (BFRA) Germany $0.182B 0.00
Nymox Pharmaceutical (NYMX) Canada $0.181B 0.00
Eton Pharmaceuticals (ETON) United States $0.181B 0.00
DBV Technologies S.A (DBVT) France $0.179B 0.00
Cerecor (CERC) United States $0.175B 0.00
Theratechnologies (THTX) Canada $0.173B 0.00
Checkpoint Therapeutics (CKPT) United States $0.173B 0.00
CorMedix Inc (CRMD) United States $0.165B 0.00
Lexicon Pharmaceuticals (LXRX) United States $0.162B 7.55
Exicure (XCUR) United States $0.161B 0.00
Abeona Therapeutics (ABEO) United States $0.155B 0.00
Aytu Bioscience (AYTU) United States $0.154B 0.00
Aptinyx (APTX) United States $0.152B 0.00
SESEN BIO, INC (SESN) United States $0.151B 0.00
Five Prime Therapeutics (FPRX) United States $0.149B 0.00
Nicox SA (NICXF) France $0.149B 0.00
AVEO Pharmaceuticals (AVEO) United States $0.147B 0.00
GENFIT S.A (GNFT) France $0.146B 0.00
VolitionRX (VNRX) United States $0.145B 0.00
Lineage Cell Therapeutics (LCTX) United States $0.138B 0.00
Bellus Health (BLU) Canada $0.132B 0.00
AquaBounty Technologies (AQB) United States $0.130B 0.00
Celyad SA (CYAD) Belgium $0.129B 0.00
VTv Therapeutics (VTVT) United States $0.129B 0.00
Applied Genetic Technologies (AGTC) United States $0.126B 0.00
Cidara Therapeutics (CDTX) United States $0.125B 0.00
Catabasis Pharmaceuticals (CATB) United States $0.119B 0.00
Strongbridge Biopharma (SBBP) United States $0.117B 0.00
Windtree Therapeutics (WINT) United States $0.115B 0.00
Protalix BioTherapeutics (PLX) Israel $0.114B 0.00
Lumos Pharma (LUMO) United States $0.113B 0.00
Palatin Technologies (PTN) United States $0.112B 2.88
Pieris Pharmaceuticals (PIRS) United States $0.110B 0.00
Unum Therapeutics (UMRX) United States $0.106B 0.00
Orgenesis (ORGS) United States $0.105B 5.36
Gritstone Oncology (GRTS) United States $0.105B 0.00
Enzo Biochem (ENZ) United States $0.100B 0.00
Antibe Therapeutics (ATBPF) Canada $0.097B 0.00
PHASEBIO PHARMA (PHAS) United States $0.097B 0.00
Catalyst Biosciences (CBIO) United States $0.093B 0.00
AIT Therapeutics (XAIR) United States $0.083B 0.00
ARAVIVE, INC (ARAV) United States $0.082B 0.00
Oncobiologics (OTLK) United States $0.082B 0.00
Bionano Genomics (BNGO) United States $0.082B 0.00
Idera Pharmaceuticals (IDRA) United States $0.079B 0.00
Ecology Coatings (ABVC) United States $0.078B 0.00
Evogene (EVGN) Israel $0.075B 0.00
DiaMedica Therapeutics (DMAC) United States $0.074B 0.00
Clearside Biomedical (CLSD) United States $0.071B 0.00
Edesa Biotech (EDSA) Canada $0.070B 0.00
EYEPOINT PHARMACEUTICALS, INC (EYPT) United States $0.068B 0.00
Adocia (ADOCY) France $0.067B 0.00
Prima BioMed (IMMP) Australia $0.066B 0.00
Synlogic (SYBX) United States $0.066B 0.00
Aerpio Pharmaceuticals (ARPO) United States $0.064B 0.00
ASLAN Pharmaceuticals (ASLN) Singapore $0.062B 0.00
Aridis Pharmaceuticals (ARDS) United States $0.059B 0.00
Curis (CRIS) United States $0.058B 0.00
ANIXA BIOSCIENCES INC (ANIX) United States $0.057B 0.00
Appili Therapeutics (APLIF) Canada $0.056B 0.00
AmpliPhi Biosciences (ARMP) United States $0.056B 0.00
Proteostasis Therapeutics (PTI) United States $0.056B 0.00
TRACON Pharmaceuticals (TCON) United States $0.055B 0.00
Soligenix (SNGX) United States $0.055B 0.00
AnPac Bio-Medical Science (ANPC) China $0.052B 0.00
Cocrystal Pharma (COCP) United States $0.050B 0.00
Vascular Biogenics (VBLT) Israel $0.049B 0.00
Stealth BioTherapeutics (MITO) United States $0.049B 69.75
Novogen (KZIA) Australia $0.048B 0.00
Happiness Biotech Group (HAPP) China $0.048B 0.00
CollPlant Holdings (CLGN) Israel $0.045B 0.00
Genetic Technologies (GENE) Australia $0.044B 0.00
Signal Genetics (MGEN) United States $0.044B 0.00
Organovo Holdings (ONVO) United States $0.041B 0.00
Pulmatrix (PULM) United States $0.041B 0.00
IMMURON (IMRN) Australia $0.041B 0.00
Vaccinex (VCNX) United States $0.037B 0.00
ATyr Pharma (LIFE) United States $0.037B 0.00
Chanticleer Holdings (SONN) United States $0.033B 0.00
Prana Biotechnology (ATHE) Australia $0.030B 0.00
BioCardia (BCDA) United States $0.030B 0.00
OvaScience (MLND) United States $0.029B 0.00
Apricus Biosciences (SEEL) United States $0.027B 0.00
Cleveland BioLabs (CBLI) United States $0.026B 0.00
Advaxis (ADXS) United States $0.026B 0.00
Alimera Sciences (ALIM) United States $0.025B 0.00
Celsion (CLSN) United States $0.024B 0.00
Acorda Therapeutics (ACOR) United States $0.024B 0.00
Aptevo Therapeutics (APVO) United States $0.023B 0.00
Sunesis Pharmaceuticals (SNSS) United States $0.023B 0.00
Cesca Therapeutics (THMO) United States $0.020B 0.00
PLANET GREEN HOLDINGS CORP (PLAG) China $0.020B 0.00
Spherix (AIKI) United States $0.019B 0.00
AEterna Zentaris (AEZS) United States $0.019B 0.00
Titan Pharmaceuticals (TTNP) United States $0.018B 0.00
MYOS RENS Technology (MYOS) United States $0.016B 0.00
Cyclacel Pharmaceuticals (CYCC) United States $0.016B 0.00
BioPharmX (TMBR) United States $0.011B 0.00
Neuralstem (SNCA) United States $0.010B 0.00
Benitec Biopharma (BNTC) Australia $0.007B 0.00
Entera Bio (ENTX) Israel $0.000B 0.00